-

Veradigm Issued Patent for Risk Adjustment Method and Apparatus

Veradigm is providing health plans with a patent-protected method to support risk adjustment programs through “Dynamic Intervention Planning”

CHICAGO--(BUSINESS WIRE)--Veradigm, a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), today announced that its method and apparatus for risk adjustment patent (“Dynamic Intervention Planning”) has been issued by the United States Patent and Trademark Office (USPTO).

The patent covers the systems that power Veradigm’s Dynamic Intervention Planning process. These systems enable Veradigm’s clients to find, size, monetize, prioritize, and resolve opportunities across different lines of business.

“Dynamic Intervention Planning can result in a greater risk adjustment lift for our clients. It allows our clients to properly focus their efforts to be more impactful,” says Tom Langan, President and Chief Commercial Officer of Veradigm. “This means less waste, greater precision in revenue projections, and more control over how our clients manage their programs.”

Through this patent, only Veradigm can identify service item management opportunities, ascribe levels of confidence, and size Risk Adjustment Factor points. This Veradigm Network solution can also recommend and prioritize interventions, communicate opportunities for action electronically to external devices, and dynamically update all of this as the health plan member’s data builds and refines over time.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. Some healthcare technology companies deliver clinical data for biopharma and health plans, some help turn that data into insights, others serve healthcare providers directly by providing point-of-care clinical software and patient outreach platforms, Veradigm does all of these and more. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.

For more information on Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2022 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Contacts

Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@allscripts.com

Media:
Amanda Cohen
412-919-2417
Amanda.Cohen@veradigm.com

Allscripts Healthcare Solutions Logo
Allscripts Healthcare Solutions Logo

Allscripts Healthcare Solutions

NASDAQ:MDRX

Release Versions

Contacts

Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@allscripts.com

Media:
Amanda Cohen
412-919-2417
Amanda.Cohen@veradigm.com

More News From Allscripts Healthcare Solutions

Veradigm Launches Enhanced Ambient Scribe Capabilities

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced enhancements to the artificial intelligence (AI) enhanced Ambient Scribe solution for Veradigm EHR customers. This milestone reflects Veradigm’s commitment to delivering evolved AI solutions that improve clinical documentation, support clinical decision-making, and enhance patient care. Since its launch last year, Veradigm Ambient Scribe has developed into a robus...

Veradigm Adds Sentara Health Plans to Veradigm Payer Insights Solution

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today a new agreement with Sentara Health Plans, a prominent regional health plan, serving more than one million members. Sentara will implement the Veradigm Payer Insights software solution to deliver patient-specific care gap alerts within the electronic health record (EHR) systems used by its network providers. Veradigm Payer Insights displays critical care gap alert...

Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today appoints Tehsin Syed, a healthcare technology leader with over two decades of experience, as Chief Product and Technology Officer. Syed most recently served as General Manager, AWS Health AI (Amazon Web Services). Under his leadership, the organization scaled as a growth engine, with net-new products for ambient clinical documentation, genomics, and medical imaging, and int...
Back to Newsroom